F H van den Hoogen
Overview
Explore the profile of F H van den Hoogen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
1839
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van den Ende C, Minten M, Mahler E, Hoogeboom-Leseman M, van den Hoogen F, Poortmans P
Osteoarthr Cartil Open
. 2022 Dec;
2(1):100041.
PMID: 36474557
No abstract available.
2.
Mahler E, den Broeder A, Woodworth T, Busch V, van den Hoogen F, Bijlsma J, et al.
Scand J Rheumatol
. 2017 Mar;
46(5):396-406.
PMID: 28276959
Objectives: There is a need to define and validate measures of clinical worsening in knee and hip osteoarthritis (OA). The objectives of this exploratory project were: (i) to characterize worsening...
3.
Mahler E, Zweers M, van Lent P, Blom A, van den Hoogen F, van den Berg W, et al.
Scand J Rheumatol
. 2014 Sep;
44(1):56-60.
PMID: 25179566
Objectives: To explore the association between S100A8/A9 serum levels with clinical and structural characteristics of patients with established knee, hip, or hand osteoarthritis (OA). Method: A cross-sectional exploratory study was...
4.
Denton C, Engelhart M, Tvede N, Wilson H, Khan K, Shiwen X, et al.
Ann Rheum Dis
. 2008 Sep;
68(9):1433-9.
PMID: 18782794
Aim: The safety and potential efficacy of a chimaeric anti-tumour necrosis factor alpha monoclonal antibody (infliximab) were examined in diffuse cutaneous systemic sclerosis (dcSSc). Methods: A 26-week open-label pilot study...
5.
Roelofs M, Joosten L, Abdollahi-Roodsaz S, van Lieshout A, Sprong T, van den Hoogen F, et al.
Arthritis Rheum
. 2005 Jul;
52(8):2313-22.
PMID: 16052591
Objective: To evaluate the expression of Toll-like receptors (TLRs) 3 and 7 in synovium and to study potential differences in the maturation and cytokine production mediated by TLR-2, TLR-3, TLR-4,...
6.
Hengstman G, van Venrooij W, van den Hoogen F, van Engelen B
Ned Tijdschr Geneeskd
. 2003 Aug;
147(31):1485-9.
PMID: 12924076
In three women, aged 60, 45 and 38 years, who presented with exertional dyspnoea (due to lung fibrosis) and Raynaud's phenomenon, dermatomyopathy and Raynaud's phenomenon, and symmetrical arthralgia and myalgia,...
7.
Akesson A, Fiori G, Krieg T, van den Hoogen F, Seibold J
Clin Exp Rheumatol
. 2003 Aug;
21(3 Suppl 29):S5-8.
PMID: 12889214
This report makes recommendations for standardized techniques of data gathering and collection regarding: 1) skin involvement 2) joint and tendon involvement, and 3) involvement of the skeletal muscles. The recommendations...
8.
van Heereveld H, Laan R, van den Hoogen F, Malefijt M, Novakova I, van de Putte L
Ann Rheum Dis
. 2001 Sep;
60(10):974-6.
PMID: 11557656
The need for prevention of venous thromboembolism (VTE) after total hip or knee replacement is obvious. However, the optimal regimen to achieve this remains to be defined. In patients with...
9.
Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman A, DAngelo S, et al.
Ann Rheum Dis
. 2001 May;
60(6):592-8.
PMID: 11350848
Objective: To develop criteria for disease activity in systemic sclerosis (SSc) that are valid, reliable, and easy to use. Methods: Investigators from 19 European centres completed a standardised clinical chart...
10.
Della Rossa A, Valentini G, Bombardieri S, Bencivelli W, Silman A, DAngelo S, et al.
Ann Rheum Dis
. 2001 May;
60(6):585-91.
PMID: 11350847
Objective: To investigate the existence of differences among European referral centres for systemic sclerosis (SSc) in the pattern of attendance and referral and in the clinical and therapeutical approaches. Methods:...